Global Endovascular Stent Grafts Market – Industry Trends and Forecast to 2031

Endovascular Stent Grafts Market Analysis and Size

Peripheral Artery Disease (PAD) involves the narrowing or blockage of arteries outside the heart, typically in the legs, due to atherosclerosis. Endovascular stent grafts are increasingly used to treat PAD by restoring blood flow in affected arteries. These devices are deployed through minimally invasive procedures, such as angioplasty and stenting, where a stent graft is inserted to expand and support the artery walls, keeping them open and improving blood circulation. This approach helps alleviate symptoms such as leg pain (claudication), promotes healing of ulcers, and reduces the risk of limb amputation.

The global endovascular stent grafts market size was valued at USD 1.13 billion in 2023 and is projected to reach USD 17.50 billion by 2031, with a CAGR of 6.20% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation       

Market Definition

Endovascular stent grafts are medical devices used primarily in the treatment of aneurysms and certain types of vascular lesions. Unsuch as traditional open surgery, endovascular stent grafts are inserted into blood vessels through minimally invasive techniques. These grafts consist of a metal stent covered with fabric or polymer material, which helps reinforce weakened or damaged blood vessel walls and redirect blood flow, thereby reducing the risk of rupture or blockage.

Endovascular Stent Grafts Market Dynamics

Drivers                                                                                                        

• Rise in the Aging Population

As people age, they become more susceptible to vascular diseases such as aortic aneurysms and peripheral artery disease (PAD), which often require medical intervention. Endovascular stent grafts offer a minimally invasive treatment option for these conditions, appealing to elderly patients who may prefer procedures with lower risks and quicker recovery times. Moreover, advancements in healthcare have led to longer life expectancy, resulting in a larger pool of elderly individuals seeking treatment for age-related vascular issues.

• Rising Incidence of Chronic Disease

The rising incidence of chronic diseases, such as diabetes, hypertension, and obesity, significantly contributes to the demand for endovascular stent grafts. These conditions often lead to complications such as atherosclerosis, peripheral artery disease (PAD), and abdominal aortic aneurysms (AAA), which necessitate interventions to restore blood flow and prevent serious complications such as limb amputation or aneurysm rupture. Endovascular stent grafts offer a minimally invasive solution for managing these conditions, providing patients with options that reduce recovery times, hospital stays, and overall healthcare costs

Opportunities

• Growing Technological Advancements

Technological continually improve the design, materials, and functionality of stent grafts, enhancing their effectiveness and safety in treating vascular conditions such as aneurysms and peripheral artery disease (PAD). Innovations such as advanced imaging techniques (e.g., 3D imaging for precise placement), novel biomaterials for better compatibility and durability, and refined delivery systems (e.g., smaller catheters) enable more accurate and minimally invasive procedures. Additionally, ongoing research and development efforts lead to the development of next-generation stent grafts with features such as better flexibility, reduced migration rates, and enhanced long-term outcomes, thereby expanding their applicability and adoption in clinical settings worldwide.

• Rising Healthcare Expenditure

As countries allocate more resources to healthcare infrastructure and technologies, there is greater affordability and accessibility to advanced medical treatments, including endovascular procedures. This increased investment supports hospitals and healthcare facilities in adopting and offering minimally invasive interventions such as stent grafts for conditions such as aortic aneurysms and peripheral artery disease (PAD). Healthcare expenditure growth often correlates with improved patient outcomes and satisfaction, prompting further adoption of these technologies. The trend also fosters research and development, leading to continuous innovation in stent graft design, materials, and delivery systems, thereby expanding the market and enhancing treatment efficacy.

Restraints/Challenges

• Alternative Treatment Options

Traditional open surgeries, though more invasive, remain effective and established methods for treating vascular conditions such as aneurysms and peripheral artery disease (PAD). Additionally, non-invasive treatments such as medication management, lifestyle modifications (e.g., diet, exercise), and risk factor control (e.g., smoking cessation) are often recommended as initial therapies. These alternatives may be preferred by patients and physicians seeking to avoid the risks associated with invasive procedures or those looking for more conservative approaches. The availability and accessibility of alternative treatments vary, influencing patient and provider decision-making.

• High Cost Constraints

The initial expense associated with stent graft devices and endovascular procedures can be substantial, limiting access for patients and healthcare facilities, particularly in regions with constrained healthcare budgets. The high cost includes not only the device itself but also factors such as specialized equipment, hospital fees, and physician expertise. Additionally, follow-up care and potential complications may further escalate costs over time. This financial burden can deter adoption by healthcare providers and influence patient decision-making, impacting market growth and accessibility of these advanced treatments, especially in underserved or economically challenged areas.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Endovascular Stent Grafts Market Scope

The market is segmented on the basis of type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Туре

• Ѕуnthеtіс
• Віоlоgісаl
• Віоѕуnthеtіс

End User

• Hospitals
• Ambulatory Surgical Centers
• Others

Endovascular Stent Grafts Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, type and end user referenced above.

The countries covered in the market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market primarily due to the region experiences a high prevalence of cardiovascular diseases (CVDs), driving the demand for advanced treatment options such as stent grafts. North America boasts well-established healthcare facilities and infrastructure that support the adoption of cutting-edge medical technologies. Additionally, a strong emphasis on healthcare research and development in the region contributes to continuous innovation and improvement in stent graft technologies.

Asia-Pacific is expected to experience the highest growth in the market due to increasing health awareness among the population, leading to greater demand for advanced medical technologies and treatments. Rising incidences of vascular diseases, coupled with improving healthcare infrastructure and expanding healthcare expenditure in countries like China, India, and Japan, contribute to this trend. Additionally, ongoing urbanization and aging populations further fuel the demand for innovative medical interventions, including minimally invasive procedures like endovascular stent grafts, driving market expansion in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Endovascular Stent Grafts Market Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

• BD (U.S.)
• Cook (U.S.)
• B. Braun Melsungen AG (Germany)
• Medtronic (Ireland)
• Terumo Corporation (Japan)
• Lombard Medical (U.K.)
• Johnson and Johnson Services, Inc (U.S.)
• Cardinal Health (U.S.)
• Boston Scientific Corporation (U.S.)
• BD (U.S.)
• Medtronic (Ireland)
• MicroPort Scientific Corporation (China)
• Merit Medical Systems (U.S.)

SKU-69049